Systemic Inflammation and CAR-T Specific Toxicities as Major Drivers of Nonrelapse Mortality: Analysis from the Italian Prospective Observational CART-SIE Study
Open Access
- 23 February 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (MAD-2022-12376059)
- Ministero della Salute (E3-2022-23683269-PNC-HLS-TA)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
- Associazione Italiana Contro le Leucemie - Linfomi e Mieloma
- Fondazione AIRC per la ricerca sul cancro ETS
- Associazione Italiana per la Ricerca sul Cancro (IG 2024)
- Associazione Italiana per la Ricerca sul Cancro (31005)
This publication has 35 references indexed in Scilit:
- Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin LymphomaJAMA Network Open, 2025
- CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesThe Lancet Rheumatology, 2024
- Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortalityJournal of Allergy and Clinical Immunology, 2024
- Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell LymphomaTransplantation and Cellular Therapy, 2024
- Diabetes and infection: review of the epidemiology, mechanisms and principles of treatmentDiabetologia, 2024
- Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyTransplantation and Cellular Therapy, 2023
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design studyThe Lancet, 2020
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysisThe Lancet Haematology, 2017
- Inflammation and type 2 diabetesDiabetes & Metabolism, 2012